Methoxyflurane
| Methoxyflurane | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 164.96 g/mol [1] |
| Appearance | Liquid [1] |
| Odor | Fruity [1] |
| Density | 1.426 at 68 °F (NTP, 1992) - Denser than water; will sink [1] |
| Melting point | -31 °F (NTP, 1992) [1] |
| Boiling point | 220.3 °F at 760 mmHg (NTP, 1992) [1] |
| Solubility | less than 1 mg/mL at 66 °F (NTP, 1992) [1] |
| Predicted LogP | 2.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C3H4Cl2F2O |
| IUPAC name | 2,2-dichloro-1,1-difluoro-1-methoxyethane |
| SMILES | COC(C(Cl)Cl)(F)F |
| InChI | InChI=1S/C3H4Cl2F2O/c1-8-3(6,7)2(4)5/h2H,1H3 |
| InChIKey | RFKMCNOHBTXSMU-UHFFFAOYSA-N |
| CAS number | 76-38-0 |
| UNII | 30905R8O7B |
| PubChem CID | 4116 |
| Pharmacokinetics[] | |
|---|---|
| Onset | Rapid after 6-10 breaths |
| Duration of action | Typically up–30–60 minutes depending on the frequency of breaths |
| Metabolism | 70% |
| Routes of administration | Inhalation |
| Toxicity [] | |
|---|---|
| LD50 | Rat: - Oral: 3600 mg/kg [1] |
Methoxyflurane (also known as Methoxyfluran, Penthrane, Methoflurane, Anecotan, 2,2-Dichloro-1,1-difluoroethyl methyl ether, Metoxfluran, Metoxifluran, Analgizer, Inhalan or Metofane) is a substance of the ether class.
Chemistry
Stereochemistry []
Methoxyflurane is achiral.
Druglikeness
Lipinski's rule of five
Methoxyflurane matches Lipinski's rule of five.Pharmacology
ATC Classification
- nervous system (N)
- analgesics (N02)
- other analgesics and antipyretics (N02B)
- other analgesics and antipyretics (N02BG)
- methoxyflurane (N02BG09)
MeSH Classification
- anesthetics, inhalation (M0027998)
Mechanism of action []
Methoxyflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. Methoxyflurane also activates calcium dependent ATPase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. It also appears to bind the D subunit of ATP synthase and NADH dehydogenase. Methoxyflurane also binds to the GABA receptor, the large conductance Ca<sup>2+</sup> activated potassium channel, the glutamate receptor and the glycine receptor. [1]
Interactions []
Legal status []
- Australia: Methoxyflurane is a Schedule 4.[3][4]
- Brazil: Methoxyflurane is a C1.[5]
- Canada: Methoxyflurane is Prescription only.[6]
- United Kingdom: Methoxyflurane is Prescription only.[7]
- United States: Methoxyflurane is a Withdrawn from market.
- European Union: Methoxyflurane is Prescription only.[8]
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4116, Methoxyflurane. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4116
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Methoxyflurane. UNII: 30905R8O7B. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/30905R8O7B
Penthrox methoxyflurane inhalation bottle (43144). Therapeutic Goods Administration (TGA). 12 August 2022. https://www.tga.gov.au/resources/artg/43144
Penthrox (311927). Therapeutic Goods Administration (TGA). 12 August 2022. https://www.tga.gov.au/resources/artg/311927
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Regulatory Decision Summary for Penthrox. 23 October 2014. https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?lang=en&linkID=RDS00391
Penthrox 99.9%, 3 ml inhalation vapour, liquid. (emc). 5 April 2023. https://www.medicines.org.uk/emc/product/1939/smpc
List of nationally authorised medicinal products : Active substance: methoxyflurane : Procedure no. PSUSA/00010484/202005. Ema.europa.eu. https://www.ema.europa.eu/documents/psusa/methoxyflurane-list-nationally-authorised-medicinal-products-psusa/00010484/202005_en.pdf
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 07:20:05 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 07:20:01 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 07:20:01 |
| gsrs | ok | 2026-11-20 07:20:01 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015162) | 2026-11-20 07:20:01 |
| kegg | ok | 2026-11-20 07:20:03 |
| pubchem | ok | 2026-11-20 07:20:00 |
| missing (no r/tripreports posts mention it) | 2026-11-20 07:20:01 | |
| sider | missing (not in SIDER) | 2026-11-20 07:20:01 |
| structure | ok | 2026-11-20 07:20:01 |
| wikipedia | ok | 2026-11-20 07:20:01 |